StocksFundsScreenerSectorsWatchlists
SWKH

SWKH - SWK Holdings Corp Stock Price, Fair Value and News

17.18USD-0.04 (-0.23%)Delayed

Market Summary

SWKH
USD17.18-0.04
Delayed
-0.23%

SWKH Stock Price

View Fullscreen

SWKH RSI Chart

SWKH Valuation

Market Cap

214.7M

Price/Earnings (Trailing)

13.51

Price/Sales (Trailing)

5.69

EV/EBITDA

11.04

Price/Free Cashflow

14.92

SWKH Price/Sales (Trailing)

SWKH Profitability

EBT Margin

38.70%

Return on Equity

5.67%

Return on Assets

4.75%

Free Cashflow Yield

6.7%

SWKH Fundamentals

SWKH Revenue

Revenue (TTM)

37.8M

Rev. Growth (Yr)

0.95%

Rev. Growth (Qtr)

10.35%

SWKH Earnings

Earnings (TTM)

15.9M

Earnings Growth (Yr)

0.42%

Earnings Growth (Qtr)

-36.43%

Breaking Down SWKH Revenue

Last 7 days

-0.5%

Last 30 days

-1.5%

Last 90 days

0.7%

Trailing 12 Months

-3.3%

How does SWKH drawdown profile look like?

SWKH Financial Health

Current Ratio

3.01

SWKH Investor Care

Buy Backs (1Y)

2.47%

Diluted EPS (TTM)

1.25

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202340.6M39.6M38.7M37.8M
202252.5M48.8M45.2M41.5M
202141.6M46.4M51.3M56.2M
202032.7M34.7M036.7M
201928.6M27.4M29.1M30.7M
201829.4M30.1M30.5M26.0M
201732.0M29.5M30.7M37.5M
201622.9M26.1M24.6M22.4M
201519.5M21.6M23.6M23.5M
20149.7M12.0M14.2M17.4M
20131.1M2.0M3.5M6.4M
2012244.0K220.0K205.0K682.0K
2011468.5K407.0K345.5K284.0K
2010000530.0K

Tracking the Latest Insider Buys and Sells of SWK Holdings Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Apr 01, 2024
albright jerry
acquired
13,757
16.88
815
-
Apr 01, 2024
hatcher robert k.
acquired
13,757
16.88
815
-
Apr 01, 2024
pennington marcus edward
acquired
31,498
16.88
1,866
-
Apr 01, 2024
dotter laurie l.
acquired
13,757
16.88
815
-
Mar 01, 2024
staggs joe david jr
acquired
-
-
35,881
president
Jan 02, 2024
hatcher robert k.
acquired
13,749
17.95
766
-
Jan 02, 2024
pennington marcus edward
acquired
27,499
17.95
1,532
-
Jan 02, 2024
dotter laurie l.
acquired
13,749
17.95
766
-
Jan 02, 2024
albright jerry
acquired
13,749
17.95
766
-
Oct 02, 2023
pennington marcus edward
acquired
31,509
15.85
1,988
-

1–10 of 50

Which funds bought or sold SWKH recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 12, 2024
Dynamic Advisor Solutions LLC
added
0.31
-785
389,128
0.01%
Apr 05, 2024
CWM, LLC
sold off
-100
-1,000
-
-%
Mar 11, 2024
VANGUARD GROUP INC
added
0.54
421,820
3,967,320
-%
Mar 05, 2024
GREENWOOD CAPITAL ASSOCIATES LLC
added
94.82
838,161
1,555,540
0.10%
Mar 01, 2024
GOLDMAN SACHS GROUP INC
added
101
261,979
473,486
-%
Feb 28, 2024
AMERICAN INTERNATIONAL GROUP, INC.
reduced
-2.5
2,521
32,115
-%
Feb 15, 2024
BARCLAYS PLC
added
434
77,000
92,000
-%
Feb 15, 2024
Farther Finance Advisors, LLC
new
-
263
263
-%
Feb 15, 2024
SkyView Investment Advisors, LLC
sold off
-100
-415,000
-
-%
Feb 15, 2024
State of Wyoming
added
101
44,210
79,726
0.01%

1–10 of 49

Are Funds Buying or Selling SWKH?

Are funds buying SWKH calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own SWKH
No. of Funds

Unveiling SWK Holdings Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
m3 partners lp
6.16%
770,770
SC 13G/A
Feb 13, 2024
cannell capital llc
6.59%
823,652
SC 13G/A
Apr 17, 2023
cannell capital llc
7.48%
958,127
SC 13G/A
Feb 10, 2023
m3 partners lp
6.20%
795,245
SC 13G/A
Jul 11, 2022
m3 partners lp
5.09%
653,692
SC 13G
Jan 10, 2022
carlson capital l p
66.3%
8,493,088
SC 13D/A
Dec 28, 2021
carlson capital l p
66.3%
8,493,088
SC 13D/A
Nov 23, 2021
carlson capital l p
66.3%
8,493,088
SC 13D/A
Nov 12, 2021
carlson capital l p
66.4%
8,493,088
SC 13D/A
Jun 23, 2021
cannell capital llc
7.56%
968,099
SC 13D/A

Recent SEC filings of SWK Holdings Corp

View All Filings
Date Filed Form Type Document
Apr 03, 2024
4
Insider Trading
Apr 03, 2024
4
Insider Trading
Apr 03, 2024
4
Insider Trading
Apr 03, 2024
4
Insider Trading
Mar 22, 2024
8-K
Current Report
Mar 21, 2024
8-K
Current Report
Mar 20, 2024
10-K
Annual Report
Mar 19, 2024
8-K
Current Report
Mar 05, 2024
4
Insider Trading
Feb 14, 2024
SC 13G/A
Major Ownership Report

Peers (Alternatives to SWK Holdings Corp)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
111.6B
17.9B
-6.62% 7.31%
20.29
6.25
-0.08% 6.26%
87.1B
8.0B
-2.48% 39.71%
62.62
10.86
-5.81% -20.41%
40.7B
20.6B
-0.77% 22.07%
12.4
1.97
87.93% 27.71%
40.3B
3.6B
-0.93% 57.78%
84.87
11.08
18.87% 183.11%
13.0B
7.9B
-8.18% -8.01%
13.43
1.65
-1.81% -3.56%
MID-CAP
6.8B
5.7B
-1.56% -11.63%
-20.45
1.19
-5.50% -148.79%
5.2B
2.1B
-0.75% 12.13%
7.79
2.55
-11.67% -41.28%
3.7B
-
-1.95% -11.26%
14.14
-
- -3.64%
3.4B
975.1M
-1.67% 19.97%
15.27
3.48
-1.83% 7.51%
3.3B
489.6M
-4.02% 9.27%
25.91
6.83
-13.63% -24.55%
2.6B
708.5M
-1.51% 10.53%
21.25
3.69
14.59% 19.23%
SMALL-CAP
870.6M
241.7M
-8.77% -28.12%
-126.51
3.6
21.87% -123.56%
868.5M
426.6M
0.62% -
13.2
2.04
2.25% -34.59%
16.4M
746.8M
146.39% -59.51%
-3.54
0.02
15.88% -226.93%
695.9K
25.3M
-4.91% -13.49%
0.02
0.03
137.10% 176.58%

SWK Holdings Corp News

Latest updates
Defense World • 33 hours ago

SWK Holdings Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Revenue10.4%10.009.009.009.0010.0014.0012.0011.0011.0010.0010.009.009.008.007.007.006.006.009.007.006.00
Costs and Expenses92.4%-0.33-4.33-4.67-5.324.00-6.76-1.74-5.29-49.897.006.006.008.009.008.009.003.001.002.001.0014.00
  S&GA Expenses-8.8%3.003.003.003.002.004.003.003.004.004.003.003.002.003.003.002.003.001.001.001.001.00
  R&D Expenses-0.7%1.001.002.001.002.002.001.002.002.002.002.002.001.001.001.00-0.00----
EBITDA Margin49.9%0.50*0.34*0.44*0.31*0.30*0.56*0.40*0.70*0.67*0.66*0.80*0.53*0.44*--------
Interest Expenses540.9%1.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Income Taxes-478.5%-2.23-0.391.00-0.11-7.212.000.001.002.001.004.001.00-1.34-1.001.00-8.16-0.611.001.00-0.36-1.70
Earnings Before Taxes-85.1%1.004.005.005.00-4.389.001.005.008.003.0017.004.003.00-0.12-3.411.004.005.008.004.00-7.41
EBT Margin55.6%0.39*0.25*0.36*0.23*0.23*0.49*0.34*0.63*0.59*0.54*0.63*0.27*0.10*--------
Net Income-36.4%3.004.004.005.003.007.001.003.006.002.0014.003.005.001.00-4.669.004.004.007.005.00-5.72
Net Income Margin2.5%0.42*0.41*0.45*0.36*0.33*0.38*0.26*0.50*0.46*0.47*0.57*0.32*0.14*--------
Free Cashflow49.1%6.004.005.001.003.002.00-0.864.0011.004.0015.004.008.00--------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets5.8%334316290301300292284286283277273277274257259265254248225221216
  Current Assets-68.1%12.0037.0013.009.0010.0028.0059.0046.0047.0025.0013.007.007.0017.0023.0029.0016.00---23.00
    Cash Equivalents-85.5%5.0031.007.003.006.0019.0055.0041.0043.0019.007.002.003.009.0017.0024.0011.004.0027.0039.0020.00
  Net PPE-0.7%5.005.006.006.006.006.006.006.006.006.006.005.005.003.003.001.001.001.00--0.00
  Goodwill-100.0%-8.008.008.008.008.008.008.008.008.008.008.008.008.008.008.008.005.00---
Liabilities40.9%54.0038.0017.0026.0020.0015.0013.0015.0015.0016.0015.0033.0033.0021.0027.0033.0018.0020.001.002.003.00
  Current Liabilities-84.1%4.0025.003.0012.006.005.003.005.005.005.003.0015.0015.004.009.0018.003.00---3.00
Shareholder's Equity1.0%280278274274280277272271267261258244241236232232237228223219213
  Retained Earnings0.1%-4,144-4,147-4,152-4,156-4,151-4,153-4,160-4,161-4,164-4,170-4,173-4,187-4,190-4,195-4,199-4,200-4,195-4,204-4,208-4,212-4,219
  Additional Paid-In Capital0.0%4,4254,4254,4264,4304,4314,4314,4324,4324,4324,4314,4314,4314,4314,4314,4314,4324,4324,4324,4324,4324,432
Shares Outstanding-0.1%12.0013.0013.0013.0013.0013.0013.0013.0013.0013.0013.0013.0013.00--------
Float---58.00---64.00---61.00---43.00---36.00--
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations50.0%5,7003,7994,7246642,9241,770-8034,31111,2233,82214,8794,37110,0594,0751,8173,3175,1422,5353,8597,0004,660
  Share Based Compensation-17.6%14017016435.0019059.0016685.0060719218717717917918318719314788.0010271.00
Cashflow From Investing-39095.5%-52,522-13414,790-11,082-15,573-36,73014,522-5,76715,3698,1907,371-5,169-26,111-4,580-92.00-4,3831,604-25,411-15,61612,701-2,329
Cashflow From Financing2.2%21,02320,564-15,9537,506-594-759--8.00-2,3688.00-17,241-6009,746-7,348-8,87614,226-74.00-11.00-53.00-745-1,318
  Buy Backs-75.7%2349634,599531539599------12.009031,03362.0074.0011.0053.00745-

SWKH Income Statement

2023-12-31
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenues:  
Finance receivable interest income, including fees$ 36,346$ 35,461
Pharmaceutical development1,2025,485
Other212538
Total revenues37,76041,484
Costs and expenses:  
Allowance for credit losses1,9123,491
Impairment of goodwill8,404
Interest expense1,849340
Pharmaceutical manufacturing, research and development expense3,4366,952
General and administrative11,23212,964
Change in fair value of acquisition-related contingent consideration(6,300)5,170
Depreciation and amortization expense2,5772,599
Income from operations14,6509,968
Other income (expense), net  
Unrealized net (loss) gain on warrants(55)417
Unrealized net loss on equity securities(528)
Realized loss from sale of investments(799)(151)
Foreign currency transaction gain (loss)817(215)
Income before income tax benefit14,6139,491
Income tax benefit(1,274)(4,000)
Net income$ 15,887$ 13,491
Net income per share  
Basic$ 1.26$ 1.05
Diluted$ 1.25$ 1.05
Basic12,653,00012,835,000
Diluted12,696,00012,880,000

SWKH Balance Sheet

2023-12-31
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 4,503$ 6,156
Restricted cash733
Interest and accounts receivable, net4,7293,094
Other current assets1,9041,114
Total current assets11,86910,364
Finance receivables, net274,504236,555
Collateral on foreign currency forward contract2,7502,750
Marketable investments4876
Deferred tax assets, net28,29024,480
Warrant assets1,7591,220
Goodwill8,404
Intangible assets, net6,4878,190
Property and equipment, net5,4385,840
Other non-current assets3,1091,742
Total assets334,254299,621
Current liabilities:  
Accounts payable and accrued liabilities3,9443,902
Revolving credit facility2,445
Total current liabilities3,9446,347
Contingent consideration payable4,90011,200
Unsecured senior notes, net30,781
Revolving credit facility12,350
Other non-current liabilities1,9642,145
Total liabilities53,93919,692
Stockholders’ equity:  
Preferred Stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,497,770 and 12,843,157 shares issued and outstanding at December 31, 2023 and 2022, respectively1212
Additional paid-in capital4,425,1044,430,922
Accumulated deficit(4,144,801)(4,151,005)
Total stockholders’ equity280,315279,929
Total liabilities and stockholders’ equity$ 334,254$ 299,621
SWKH
SWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector. It operates in two segments, Finance Receivables and Pharmaceutical Development. The company provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. It also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. In addition, the company engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform. Further, it intends to out-license its internal product pipeline to create novel formulations using its proprietary technology to develop treatments for patients and caregivers. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was founded in 1996 and is headquartered in Dallas, Texas.
 CEO
 WEBSITEswkhold.com
 INDUSTRYAsset Management
 EMPLOYEES23

SWK Holdings Corp Frequently Asked Questions


What is the ticker symbol for SWK Holdings Corp? What does SWKH stand for in stocks?

SWKH is the stock ticker symbol of SWK Holdings Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of SWK Holdings Corp (SWKH)?

As of Tue Apr 16 2024, market cap of SWK Holdings Corp is 214.7 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SWKH stock?

You can check SWKH's fair value in chart for subscribers.

What is the fair value of SWKH stock?

You can check SWKH's fair value in chart for subscribers. The fair value of SWK Holdings Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of SWK Holdings Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for SWKH so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is SWK Holdings Corp a good stock to buy?

The fair value guage provides a quick view whether SWKH is over valued or under valued. Whether SWK Holdings Corp is cheap or expensive depends on the assumptions which impact SWK Holdings Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SWKH.

What is SWK Holdings Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 16 2024, SWKH's PE ratio (Price to Earnings) is 13.51 and Price to Sales (PS) ratio is 5.69. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SWKH PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on SWK Holdings Corp's stock?

In the past 10 years, SWK Holdings Corp has provided 0.319 (multiply by 100 for percentage) rate of return.